GNH USA

Europe — EMA

Nefomed (Nefopam Hydrochloride)

GNH USA supplies Nefomed (Nefopam Hydrochloride), a non‑opioid analgesic for moderate acute, post‑operative and musculoskeletal pain.

Nefopam Hydrochloride

Request sourcing

1
Pack/s

What is Nefopam Hydrochloride?

Nefopam Hydrochloride, the active ingredient in Nefomed, is a non‑opioid analgesic presented as an injection for intramuscular use. It treats moderate acute pain, post‑operative pain and musculoskeletal pain in adult patients.

GNH USA supplies Nefomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nefopam Hydrochloride used for?

Nefopam Hydrochloride is used to manage pain conditions that involve central nociceptive pathways.

- Moderate acute pain: provides analgesia to reduce pain intensity in acute settings. - Post‑operative pain: helps control pain following surgical procedures. - Musculoskeletal pain: alleviates pain associated with muscle and joint injuries.

What are the side effects of Nefopam Hydrochloride?

Adverse reactions may occur with Nefomed injection.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Sweating: increased perspiration. - Dry mouth: reduced salivation. - Dizziness: sensation of light‑headedness. - Tachycardia: elevated heart rate. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring emergency care. - Severe hypotension: marked drop in blood pressure. - Cardiac arrhythmias: irregular heart rhythms. - Anaphylaxis: life‑threatening allergic reaction. - Agranulocytosis: severe reduction in white blood cells. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder.

What precautions apply to Nefopam Hydrochloride?

Before prescribing Nefomed, clinicians should consider several safety factors.

- Renal impairment: use with caution and monitor kidney function. - Hepatic impairment: assess liver status and adjust if needed. - History of seizures: avoid or use only under strict supervision. - Concomitant MAO inhibitors: contraindicated due to risk of hypertensive crisis. - Cardiovascular disease: monitor blood pressure and heart rate closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Nefopam Hydrochloride interact with?

Nefomed may interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - SSRIs or SNRIs: potential serotonin syndrome. - Anticholinergic drugs: increased anticholinergic burden.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect. - CNS depressants: may enhance sedation. - Diuretics: possible electrolyte disturbances.

Frequently asked questions

What is Nefomed used for?+
Nefomed contains Nefopam Hydrochloride, a non‑opioid analgesic indicated for the management of moderate acute pain, post‑operative pain and musculoskeletal pain in adult patients. It is administered by intramuscular injection and is typically prescribed when opioid therapy is not required or is contraindicated.
How does Nefopam Hydrochloride work?+
Nefopam Hydrochloride produces analgesia by inhibiting the re‑uptake of the neurotransmitters norepinephrine, serotonin and dopamine in the central nervous system, and by blocking voltage‑gated sodium channels. This multimodal action reduces the transmission of pain signals and modulates central pain pathways without acting on opioid receptors.
What is the usual dose of Nefomed?+
The specific dose and frequency of Nefomed are determined by the prescribing clinician based on the severity of pain, patient characteristics and clinical setting. The product is supplied as an injectable solution for intramuscular administration, and the prescriber will set the appropriate volume and dosing interval for each individual case.
Is Nefomed safe during pregnancy or breastfeeding?+
Safety data for Nefopam Hydrochloride in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Consequently, it should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk to the fetus or infant, and after careful evaluation by a healthcare professional.
How do I order Nefomed from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity of Nefomed. GNH USA works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any cold‑chain requirements—and assists with import documentation.
How does Nefomed compare with other analgesics?+
Compared with opioid analgesics, Nefomed offers pain relief without the risk of respiratory depression, dependence or typical opioid‑related side effects. Relative to other non‑opioid agents such as NSAIDs, Nefopam does not inhibit cyclo‑oxygenase enzymes, so it carries a lower risk of gastrointestinal bleeding and platelet inhibition. However, its side‑effect profile includes anticholinergic symptoms and rare serious reactions, which should be weighed against alternative therapies.
What are the storage and handling requirements for Nefomed?+
Nefomed injection should be stored at 2‑8 °C (refrigerated) in its original packaging. It must be protected from light, should not be frozen, and should be gently inverted if mixing is required—avoid shaking the vial. Prior to administration, inspect the solution for particulate matter or discoloration and discard any product that appears compromised.
How is Nefomed administered?+
Nefomed is supplied as a sterile injectable solution intended for intramuscular injection. The healthcare professional selects an appropriate muscle site, typically the deltoid or gluteal muscle, and administers the prescribed volume using a sterile needle and syringe. Proper aseptic technique and correct injection depth are essential to ensure effective analgesia and minimize injection‑site reactions.
What are the most serious risks to watch for with Nefomed?+
Although uncommon, serious adverse reactions to Nefomed can include seizures, severe hypotension, cardiac arrhythmias, anaphylactic or anaphylactoid reactions, agranulocytosis, and severe skin disorders such as Stevens‑Johnson syndrome. Patients should be monitored for any signs of these events, and immediate medical attention is required if they occur. Prompt discontinuation of the drug is recommended upon identification of a serious reaction.
Who should not use Nefomed?+
Nefomed is contraindicated in patients with known hypersensitivity to Nefopam or any component of the formulation. It should also be avoided in individuals with a history of seizures, uncontrolled hypertension, severe cardiac disease, or those currently receiving monoamine oxidase inhibitors. Caution is advised in patients with renal or hepatic impairment, and the drug should be used only under medical supervision in these populations.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nefopam Hydrochloride
Route
Intramuscular Use
Manufacturer
Medochemie Iberia, S.A.
Origin
EU

Related products

Acupan

Acupan

Nefopam Hydrochloride

Biocodex
EU
Acupan

Acupan

Nefopam Hydrochloride

Biocodex
EU
Anefaltic

Anefaltic

Nefopam Hydrochloride

Uab Sanoswiss
EU
Anefaltic

Anefaltic

Nefopam Hydrochloride

Uab Sanoswiss
EU